Health Condition 1: J329- Chronic sinusitis, unspecified
Conditions
Interventions
Intervention1: Sharbat-e-Banafsha (oral): Sharbat-e-Banafsha will be given in the dose of 25 ml twice a day orally for 6 weeks
Control Intervention1: Joshandha Gaozaban(oral): Joshandha Gaozaban will
Sponsors
State Unani Medical College Prayagraj
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients fulfilling AAO-HNS criteria that is at least two major criteria (Nasal obstruction or blockage, anterior or posterior nasal discharge, Facial pain /congestion, Purulence in a nasal cavity on examination, Anosmia/ Hyposmia) or one major and two minor criteria (Halitosis, earache, dental pain, cough, fatigue) 2 patients had an opacity of X-ray paranasal sinuses (waters view) ranging from +1 (Mucosal thickening) to +3 (complete opaque antrum) grading. 3 Patients of either sex. 4 Patients in the age group of 18 to 60 years. 5 Patients with involvement of any sinus. 6 Those who give written consent.
Exclusion criteria
Exclusion criteria: 1 Child below 18 years of age. 2 Patients above 60 years of age. 3 Pregnant & lactating mothers. 4 Patients who fail to give consent. 5 Patients who fail to follow up. 6 Mentally retarded persons. 7 Patients with Malignancy of the nose or paranasal sinuses. 8 Patients have a history of any surgery of the nose or paranasal sinuses. 9 Patients have a history of any foreign body in their nose. 3Patient have a history of trauma to the nose or sinus areas. 10 Patients suffering from any congenital or acquired structural abnormality of the nasal cavity. 11 Any medical condition where the physician feels that participation in the study could be detrimental to patientsÂ? wellbeing. 12 Patients of pulmonary Kochs or patients having history of epistaxis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 reduction in AAO-HNS criteria 2 reduction in X-ray paranasal sinuses (waters view) ranging from +1 (Mucosal thickening) to +3 (complete opaque antrum) grading.Timepoint: 0 and 6 week | — |
Secondary
| Measure | Time frame |
|---|---|
| improvement in clinical featuresTimepoint: 0 and 6 week | — |
Countries
India
Contacts
Public ContactDr Usamah Ahmad
state Unani Medical College
Outcome results
None listed